Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
This section explains why investors might choose an Equal Weighted Index, focusing on balanced exposure and straightforward rebalancing.
22,679 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Two consumer stars with very different paths battle for investors' attention. One mixes health-forward fast-casual ex...
Zscaler's Q2 2026 earnings signal exciting momentum across its three growth pillars. This article breaks down the dri...
Two clinical-stage biotech names, two distinct paths to value. This guide breaks down Dyne Therapeutics and Viking Th...
SoundHound AI is delivering impressive revenue momentum, but its stock has tumbled. This analysis breaks down the dri...
Tech stocks can swing fast. When shares intel have plummeted, investors must separate noise from fundamentals. This g...
Debt can feel like a roadblock to big financial goals. This guide lays out a clear, four-debt plan and actionable ste...
Travel trends shifting—here’s it’s changing where guests stay, how long they visit, and what hosts can charge. This g...
Bitcoin has skyrocketed from a fringe project to a multi-trillion-dollar asset, while gold remains the timeless store...
A sharp slide in UPS shares invites questions: is this a buying opportunity or a red flag? This guide breaks down the...
A practical, fresh look at worthington steel (ws) 2026. This guide breaks down earnings signals, margins, and capital...
Tesla stock can swing on headlines and catalysts. This guide shows you how to decide whether you should wait tesla st...